Details for Patent: 8,383,659
✉ Email this page to a colleague
Which drugs does patent 8,383,659 protect, and when does it expire?
Patent 8,383,659 protects XDEMVY and is included in one NDA.
This patent has twenty-seven patent family members in twenty-three countries.
Drugs Protected by US Patent 8,383,659
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,383,659
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2379537 | ⤷ Subscribe | CR 2017 00034 | Denmark | ⤷ Subscribe |
| European Patent Office | 2379537 | ⤷ Subscribe | 300891 | Netherlands | ⤷ Subscribe |
| European Patent Office | 2379537 | ⤷ Subscribe | 1790037-4 | Sweden | ⤷ Subscribe |
| European Patent Office | 2379537 | ⤷ Subscribe | LUC00030 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 2379537 | ⤷ Subscribe | 17C0006 | France | ⤷ Subscribe |
| European Patent Office | 2379537 | ⤷ Subscribe | 122017000053 | Germany | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
